Joined “i2.JP”, an open innovation initiative of AstraZeneca
Oct 4,2022
iBody joined “i2.JP” that is an open innovation initiative of AstraZeneca to connect healthcare professionals, local governments, academia and private companies, designed to jointly work out collective and practical optimal answers toward the solution of issues in the healthcare field.
MORE DETAILS